Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
27.49
-1.50 (-5.17%)
At close: Nov 20, 2024, 4:00 PM
27.74
+0.25 (0.91%)
After-hours: Nov 20, 2024, 7:09 PM EST
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $3.42 billion as of November 21, 2024. Its market cap has decreased by -38.99% in one year.
Market Cap
3.42B
Enterprise Value
3.49B
1-Year Change
-38.99%
Ranking
Category
Stock Price
$27.49
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $3.42B, an increase of 394.82%. That is a compound annual growth rate of 25.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Envista Holdings | 3.55B |
| ImmunityBio | 3.49B |
| Denali Therapeutics | 3.48B |
| Acadia Healthcare Company | 3.45B |
| Neogen | 3.29B |
| BrightSpring Health Services | 3.25B |
| Bausch Health Companies | 3.08B |
| MoonLake Immunotherapeutics | 3.06B |